Kindai University · Faculty of Pharmaceutical Sciences · 教授

Research keywords点眼製剤・経皮吸収製剤・白内障・網膜・結晶多形・ナノパーティクル（ナノ医薬品）・ナノエマルション・一酸化窒素・角膜・水晶体

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Oral Administration System Based on Meloxicam Nanocrystals: Decreased Dose Due to High Bioavailability Attenuates Risk of Gastrointestinal Side Effects.
• Nasal Absorption Enhancement of Mometasone Furoate Nanocrystal Dispersions.
• Anti-inflammatory effects of water-dispersible hesperetin on endotoxin-induced uveitis in rats involving the nuclear factor κB and Wnt/β-catenin signaling pathways.
• Copolymerized Polymers Based on Cyclodextrins and Cationic Groups Enhance Therapeutic Effect of Rebamipide in the N-Acetylcysteine-Treated Dry Eye Model.

• 薬物ナノ結晶を装填したin situゲル化点眼液の開発と網膜症治療への応用
• 虹彩iPS細胞を用いた電気生理機能を有する三次元網膜再生と薬物安全性評価法の開発
• ナノ化技術を用いた点眼による網膜療法の確立と緑内障治療への応用
• 眼深部組織を標的とした次世代型ナノ点眼製剤の開発と網膜症治療への応用

• Official profile